Revised SPCs: Lipitor (atorvastatin) film-coated tablets

Revised SPCs: Lipitor (atorvastatin) film-coated tablets – all strengths
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Cardiovascular system disorders
Summary
The information in section 4.4 on immune-mediated necrotizing myopathy, which has been reported very rarely during or after treatment with some statins, has been updated to bring it in line with that advised by the PRAC.
UKMi comment
The PRAC recommendations, which relate to all medicinal products containing atorvastatin, simvastatin, pravastatin, fluvastatin, pitavastatin or lovastatin, can be viewed at the link below.
Related links: PRAC recommendation

Revised SPCs: Lipitor (atorvastatin) film-coated tablets – all strengths